Menu

Update: Iranian Researcher Detained at US Airport

The cancer scientist and his family have been sent home, and an official claims that his detention was not triggered by the Trump travel ban.

Jul 10, 2017
Bob Grant

FLICKR, HILDGRIMUpdate (July 13): Dehnavi and his family were sent back to Iran after being held at Boston’s Logan International Airport by US Customs and Border Protection (CBP) for several hours earlier this week.

“This individual was deemed inadmissible to the U.S. based on information discovered during the [customs] inspection for reasons unrelated to the [Trump administration’s] Executive Order,” the CBP says in a statement reported by several news outlets, including the Boston Globe.

According to the Associated Press and other media outlets, Iranian state television showed footage today of Dehnavi serving as the head of a student branch of a voluntary paramilitary militia in Iran, several years ago.

The television report also included a comment from Dehnavi, the Associated Press reported: “The topic of our research was health and saving ill people fighting cancer from this dangerous disease, but they didn’t allow us entry, despite, as I mentioned, all the efforts made by the American academic community.”

Officials have detained an Iranian cancer researcher at Logan International Airport in Boston since yesterday (July 10). His wife and three young children travelled from Iran with the scientist, Mohsen Dehnavi, who was hoping to start work as a visiting scholar at Boston Children’s Hospital.

“Boston Children’s hopes that this situation will be quickly resolved and Dr. Dehnavi and his family will be released and allowed to enter the U.S.,” Rob Graham, hospital spokesperson, tells STAT.

Dehnavi’s detention comes after the US Supreme Court upheld last month a twice-revised executive order from President Donald Trump that sought to ban travel to the U.S. for residents of several Muslim-majority countries, including Iran. The Court ruled, however, that current visa holders would be allowed to travel to and from the U.S. and that “a worker who accepted an offer of employment from an American company or a lecturer invited to address an American audience” would also be exempt from the travel ban. This alteration to the Trump travel ban gave international researchers some hope that they’d be able to travel freely to the U.S.

See “Supreme Court Reinstates Trump Travel Ban

According to the Boston Globe, Dehnavi was entering the U.S. on a J-1 visa—commonly issued to students and other academics studying or working at American universities—that he had secured back in May. It’s not clear whether the travel ban is to blame, but as STAT notes, the president of the president of the National Iranian American Council holds the policy responsible.

A friend of Dehnavi, Boston Children’s researcher Mohammad Rashidan, tells STAT that officials at Logan International told him the Iranian scientist and his family would likely be sent back to Iran today and would need to complete further paperwork before being allowed into the U.S. “I don’t really know what the source of the problem is,” Rashidan, who was supposed to pick up the Dehnavi family at the airport yesterday, tells STAT. “They were so worried.”

Editor’s note (July 13): The headline and subhead of this article were updated to include news of Dehnavi’s return to Iran.

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

Horizon Discovery introduces Myeloid DNA Reference Standard to support genetic testing of leukemia

Horizon Discovery introduces Myeloid DNA Reference Standard to support genetic testing of leukemia

Horizon Discovery Group plc, a global leader in gene editing and gene modulation technologies, today announced the launch of its Myeloid DNA Reference Standard. The first-to-market large cell-line derived myeloid cancer reference standard designed enables faster, more reliable and more cost-effective assay validation, to support the market in bringing routine testing into practice.

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!